SM-102 is an ionisable cationic amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). Administration of luciferase mRNA in SM-102-containing LNPs induces hepatic luciferase expression in mice. Formulations containing SM-102 have been used in the development of LNPs for delivery of mRNA-based vaccines.
Cayman Chemical’s SM-102 is distributed in Australia and New Zealand by Sapphire Bioscience.
Online:
www.sapphirebioscience.com
Phone: 02 9698 2022
Phone: 02 9698 2022
Related Products
Cayman Chemical Kinase Screening Library (96-Well)
Cayman Chemical's Kinase Screening Library (96-Well) consists of two plates and contains...
AdipoGen Life Sciences GLP-1, GIP and GCG receptor agonists
AdipoGen's range of GLP-1, GIP and GCG receptor agonists includes Liraglutide, Retatrutide,...
Integrated DNA Technologies xGen Hybridization and Wash v3 Kit
Integrated DNA Technologies (IDT) has unveiled its xGen Hybridization and Wash v3 Kit — a...
